ストックスクリーナーアプリを入手
45.00
4.44%
-2.09
前日終値:
$47.09
開ける：
$46.98
24時間の取引高:
6.88M
Relative Volume:
2.02
時価総額：
$4.05B
収益：
-
当期純損益:
$-95.90M
株価収益率:
-34.09
EPS:
-1.32
ネットキャッシュフロー:
$-79.09M
1週間 パフォーマンス:
+53.27%
1か月 パフォーマンス:
+121.67%
6か月 パフォーマンス:
+1,045%
1年 パフォーマンス:
+582.85%
1日の値動き範囲:
$44.50
$47.13
1週間の範囲:
$30.12
$48.26
52週間の値動き範囲:
$1.865
$48.26
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
名前
Terns Pharmaceuticals Inc
セクター
電話
650-525-5535 EXT.101
住所
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
TERN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
45.00 | 4.24B | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-04 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2025-11-03 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2025-10-15 | 開始されました | Truist | Buy |
| 2025-09-17 | 開始されました | Barclays | Overweight |
| 2025-09-04 | 再開されました | H.C. Wainwright | Neutral |
| 2025-02-28 | 開始されました | William Blair | Mkt Perform |
| 2024-10-31 | 開始されました | Oppenheimer | Outperform |
| 2023-06-22 | 開始されました | Mizuho | Buy |
| 2023-06-07 | 開始されました | Jefferies | Buy |
| 2023-05-31 | 開始されました | ROTH MKM | Buy |
| 2023-05-08 | 開始されました | BMO Capital Markets | Outperform |
| 2023-02-14 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-02-07 | 開始されました | UBS | Buy |
| 2022-09-12 | 開始されました | H.C. Wainwright | Neutral |
| 2021-09-14 | 再開されました | Goldman | Buy |
| 2021-03-02 | 開始されました | Cowen | Outperform |
| 2021-03-02 | 開始されました | Goldman | Buy |
| 2021-03-02 | 開始されました | JP Morgan | Overweight |
すべてを表示
Terns Pharmaceuticals Inc (TERN) 最新ニュース
Pharmaceutical Stocks To Follow TodayDecember 10th - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
Terns Pharmaceutical prices stock at $40 per share - MSN
Terns Pharmaceuticals raises $747.5 million in public offering - Investing.com
Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - The Manila Times
Citizens Analyst Raises Price Target for Terns Pharma (TERN) to $57.00 | TERN Stock News - GuruFocus
Terns Pharmaceuticals, Inc. Announces Upsized Public Offering - TradingView
Terns Pharmaceuticals stock price target raised to $57 from $35 at Citizens - Investing.com Canada
Terns Pharmaceuticals Stock Surge: Analyzing the Leap - StocksToTrade
Jefferies raises Terns Pharmaceuticals stock price target to $70 on CML data - Investing.com Canada
Terns Pharmaceuticals Stock Soars After Leukemia Drug Delivers Big Early Responses In Tough-To-Treat Patients - Stocktwits
Terns Pharmaceuticals Stock Soars Amid Promising Drug Trial - TipRanks
TERN Upsizes Stock Offering to $502M - GuruFocus
Terns Pharmaceuticals (TERN) Announces Upsized Public Offering - GuruFocus
Why Terns Pharmaceuticals (TERN) Is Up 54.9% After Upsized $650 Million Equity Raise Following TERN-701 Data - Yahoo Finance
Terns Pharmaceuticals proposes $400M equity offering - MSN
Terns Pharmaceuticals Prices Upsized $650 Million Common Stock Offering - marketscreener.com
Terns Pharmaceuticals prices upsized $650 million public offering By Investing.com - Investing.com Nigeria
Terns Pharmaceuticals (TERN): Reassessing Valuation After CARDINAL CML Data Fuels Sharp Share Price Surge - Yahoo Finance
Terns Pharmaceuticals prices upsized $650 million public offering - Investing.com
Terns announces pricing of upsized $650 million public offering at $40 per share - marketscreener.com
Terns Announces Pricing of Upsized $650 Million Public Offering | Associated Press | syndication news - Enidnews.com
Terns Announces Pricing of Upsized $650 Million Public Offering - Yahoo Finance
Terns Pharmaceuticals Stock Skyrockets: Should You Dive In? - StocksToTrade
BMO Capital Maintains Terns Pharmaceuticals (TERN) Outperform Recommendation - Nasdaq
Terns (TERN) hits all-time high on stellar leukemia treatment results - MSN
Terns (TERN) Hits All-Time High on Stellar Leukemia Treatment Results - Finviz
Terns Pharmaceuticals: CML Data Blows Wall Street AwayAgain (NASDAQ:TERN) - Seeking Alpha
Oppenheimer Raises TERN Price Target by 107% to $58 | TERN Stock News - GuruFocus
Terns Pharma (TERN) Analyst Rating Update: Price Target Raised b - GuruFocus
Barclays Raises Terns Pharma (TERN) Price Target to $56 | TERN Stock News - GuruFocus
Terns Pharmaceuticals price target raised to $56 from $35 at Truist - TipRanks
Terns Pharmaceuticals stock rating reiterated by BMO Capital with $54 target - Investing.com South Africa
Terns Pharmaceuticals (TERN) Announces $400M Public Offering Pla - GuruFocus
Mizuho Raises Terns Pharma (TERN) Price Target to $54, Maintains Outperform Rating | TERN Stock News - GuruFocus
Oppenheimer Adjusts PT on Terns Pharmaceuticals to $58 From $28, Maintains Outperform Rating - marketscreener.com
Broadcom To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
Terns Pharmaceuticals price target raised to $58 from $28 at Oppenheimer - TipRanks
Terns Pharmaceuticals (TERN) Launches $400M Public Offering - GuruFocus
Terns Pharmaceuticals price target raised to $54 from $33 at Mizuho - TipRanks
Truist Raises Price Target on Terns Pharmaceuticals to $56 From $35, Keeps Buy Rating - marketscreener.com
Mizuho Raises Price Target on Terns Pharmaceuticals to $54 From $33, Keeps Outperform Rating - marketscreener.com
Tiny Biotech Terns Takes Aim At Novartis' Leukemia Blockbuster - Benzinga
Terns Pharmaceuticals launches $400 million public offering By Investing.com - Investing.com Nigeria
H.C. Wainwright raises Terns Pharmaceuticals stock price target to $60 on CML drug data - Investing.com UK
Mizuho raises Terns Pharmaceuticals stock price target to $54 on CML drug data - Investing.com
Terns Pharma (TERN) Sees Price Target Raised by HC Wainwright | - GuruFocus
HC Wainwright & Co. Maintains Terns Pharmaceuticals (TERN) Buy Recommendation - Nasdaq
Terns Pharmaceuticals (TERN) Launches $400M Public Stock Offerin - GuruFocus
Terns Pharmaceuticals Launches $400 Million Public Offering - Nasdaq
Terns Announces Proposed Public Offering - The Manila Times
Terns Pharmaceuticals Inc (TERN) 財務データ
収益
当期純利益
現金流量
EPS
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):